Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 9/20 | 0.47 |
| ▸ | DHODH | Q02127 | 2/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.43 |
| ▸ | FABP3 | P05413 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5106872 | 0.92 | MEN1 (0.44) | MEN1ALDH1A1KMT2AL3MBTL1CHRM3 | |
| SCHEMBL16438643 | 0.89 | FABP4 (0.52) | CHRM3DHODHCHRM1CHRM2FABP4 | |
| SCHEMBL3910746 | 0.85 | AKR1C4 (0.47) | MEN1ALDH1A1KMT2AL3MBTL1CHRM3 | |
| SCHEMBL5100217 | 0.84 | HDAC7 (0.57) | MEN1ALDH1A1KMT2AL3MBTL1CHRM3 | |
| SCHEMBL5100285 | 0.84 | CHRM3 (0.56) | MEN1KMT2ACHRM3CHRM1CHRM2 | |
| SCHEMBL16438568 | 0.83 | KMT2A (0.53) | MEN1ALDH1A1KMT2AL3MBTL1CHRM3 | |
| SCHEMBL3913042 | 0.83 | CHRM1 (0.56) | MEN1ALDH1A1KMT2AL3MBTL1CHRM3 | |
| SCHEMBL16438547 | 0.82 | CHRM3 (0.56) | CHRM3S1PR4 | |
| Hydrochloric Acid SCHEMBL5099086 | 0.82 | CHRM1 (0.55) | MEN1ALDH1A1KMT2AL3MBTL1CHRM3 | |
| Trifluoroacetic Acid SCHEMBL5107023 | 0.81 | IDH2 (0.45) | MEN1ALDH1A1KMT2AL3MBTL1DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1711183-A4 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LTD (GB) | 2009-04-01 | — | — | EP | disclosed |
| US-20080249127-A1 | Muscarinic Acetylcholine Receptor Antagonists | LAINE DRAMANE I | 2008-10-09 | — | — | US | disclosed |
| EP-1711183-A2 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005067537-A2 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2005-07-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249127-A1 | Muscarinic Acetylcholine Receptor Antagonists | CHRM3, CHRNG, CHRM2 | MEN1 4053/4885ALDH1A1 2948/4885KMT2A 2510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.